查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571459

肾衰竭治疗市场规模、份额、趋势分析报告：按治疗、最终用途、地区和细分市场预测，2024-2030 年

Renal Failure Treatment Market Size, Share & Trends Analysis Report By Treatment (Dialysis, Kidney Transplantation, Drug Therapy), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

肾衰竭治疗市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球肾衰竭治疗市场规模将达到1971亿美元，2024年至2030年复合年增长率为8.3%。

该市场包括旨在管理和治疗慢性肾臟病（CKD）和终末期肾病（ESRD）的各种产品和服务。

慢性肾臟病病盛行率的增加是关键的市场驱动因素。发生率的增加主要是由于糖尿病和高血压的盛行率增加，这两种疾病是肾臟疾病的已知危险因子。随着人口老化和这些慢性疾病变得更加普遍，对肾衰竭治疗的需求将继续增长，给医疗保健系统带来额外的压力，以提供足够的照护。

对肾臟健康的认识和教育不断提高是市场的关键驱动力。旨在教育个人了解肾臟疾病的风险和症状的公共卫生宣传活动和倡议有助于早期诊断和早期治疗。认识的提高将鼓励患者儘早医，最终导致及时干预并改善肾臟疾病的管理。

2023 年 10 月，Zydus Lifesciences Limited 和 Sun Pharmaceutical Industries Limited (Sun Pharma) 签订了授权合约，共同销售 Desidustat，这是印度第一种治疗慢性肾臟病(CKD) 所致贫血的口服药物。 desidustat 的授权合约代表了市场的重大发展，为 CKD 相关贫血提供了新的口服治疗选择，加强了患者照护并扩大了印度的市场进入。

肾衰竭治疗市场报告亮点

  • 从治疗方法来看，透析疗法将占据市场主导地位，2023年销售份额将达到72.34%。 CKD 和 ESRD 盛行率的上升推动了对肾臟替代治疗的需求。这一趋势的主要驱动因素包括人口老化、透析技术的进步以及肾臟健康意识的提高。
  • 以最终用途划分，医院占据市场主导地位，2023 年销售份额最大，为 57.64%。推动这一增长的因素包括接受透析和移植手术的患者入院人数增加、肾臟护理设备的技术进步以及医院为处理复杂病例提供的综合医疗服务。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章肾衰竭治疗市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 肾衰竭治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章肾衰竭治疗市场：治疗估计与趋势分析

  • 全球肾衰竭治疗市场：治疗仪表板
  • 全球肾衰竭治疗市场：治疗变异分析
  • 全球肾衰竭治疗市场：依治疗、收益
  • 透析
  • 肾臟移植
  • 药物治疗
  • 其他的

第五章肾衰竭治疗市场：最终用途估计与趋势分析

  • 全球肾衰竭治疗市场：最终用途仪表板
  • 全球肾衰竭治疗市场：最终用途变化分析
  • 按最终用途分類的收益
  • 医院
  • 专科诊所
  • 其他的

第六章肾衰竭治疗市场：按治疗/最终用途分類的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章 竞争格局

  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • Key company market share analysis, 2023
    • NIPRO
    • Fresenius Medical Care AG
    • Baxter
    • Medtronic
    • B. Braun SE
    • Asahi Kasei Medical Co., Ltd.
    • AbbVie Inc.
    • Nikkiso Co., Ltd.
    • JMS Co., Ltd.
    • AstraZeneca
Product Code: GVR-4-68040-441-7

Renal Failure Treatment Market Growth & Trends:

The global renal failure treatment market size is anticipated to reach USD 197.1 billion by 2030 and is anticipated to grow at a CAGR of 8.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses a range of products and services designed to manage and treat chronic kidney disease (CKD) and end-stage renal disease (ESRD).

The increasing prevalence of chronic kidney disease is a significant market driver. The growing incidence is largely attributed to the rising rates of diabetes and hypertension, which are known risk factors for kidney disease. As the population ages and these chronic conditions become more prevalent, the need for renal failure treatment continues to grow, placing additional pressure on healthcare systems to provide adequate care.

Rising awareness and education about kidney health are crucial market drivers. Public health campaigns and initiatives aimed at educating individuals about the risks and symptoms of kidney disease have contributed to earlier diagnosis and treatment. The heightened awareness encourages patients to seek medical advice sooner, ultimately leading to timely interventions and improved management of kidney conditions.

In October 2023, Zydus Lifesciences Limited and Sun Pharmaceutical Industries Limited (Sun Pharma) entered a licensing agreement to co-commercialize Desidustat, the first oral drug in India to treat anemia caused by chronic kidney disease (CKD). The licensing agreement for Desidustat represents a significant development in the market by providing a novel oral treatment option for anemia associated with CKD, enhancing patient care, and expanding market access in India.

Renal Failure Treatment Market Report Highlights:

  • Based on treatment, dialysis dominated the market with the largest revenue share of 72.34% in 2023. The rising prevalence of CKD and ESRD is driving the demand for renal replacement therapies. Major factors contributing to this trend include an aging population, technological advancements in dialysis, and increased kidney health awareness
  • Based on end-use, hospitals dominated the market with the largest revenue share of 57.64% in 2023. Factors driving this growth include a rise in patient admissions for dialysis and transplant procedures, technological advancements in renal care equipment, and comprehensive healthcare services provided by hospitals that cater to complex cases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment Outlook
    • 2.2.2. End Use Outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Renal Failure Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increased prevalence of CKD
      • 3.2.1.2. Advancements in treatment technologies
      • 3.2.1.3. Rising awareness and education about kidney health
      • 3.2.1.4. Aging population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Limited Healthcare Resources and Access
  • 3.3. Renal Failure Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Renal Failure Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Renal Failure Treatment Market: Treatment Dashboard
  • 4.2. Global Renal Failure Treatment Market: Treatment Movement Analysis
  • 4.3. Global Renal Failure Treatment Market by Treatments, Revenue
  • 4.4. Dialysis
    • 4.4.1. Dialysis market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.2. Hemodialysis
      • 4.4.2.1. Hemodialysis market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.3. Peritoneal Dialysis
      • 4.4.3.1. Peritoneal Dialysis market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Kidney Transplantation
    • 4.5.1. Kidney transplantation market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.6. Drug Therapy
    • 4.6.1. Drug therapy market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.2. Antihypertensive Drugs
      • 4.6.2.1. Antihypertensive Drugs market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.3. Antianemia Therapeutics (Erythropoiesis-Stimulating Agents)
      • 4.6.3.1. Antianemia therapeutics (Erythropoiesis-Stimulating Agents) market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.4. Potassium Binders
      • 4.6.4.1. Potassium Binders market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.5. Phosphate Binders
      • 4.6.5.1. Phosphate Binders market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Renal Failure Treatment Market: End Use Estimates & Trend Analysis

  • 5.1. Global Renal Failure Treatment Market: End Use Dashboard
  • 5.2. Global Renal Failure Treatment Market: End Use Movement Analysis
  • 5.3. Global Renal Failure Treatment Market Estimates and Forecasts, By End Use, Revenue (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Specialty Clinics
    • 5.5.1. Specialty clinics market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Renal Failure Treatment Market: Regional Estimates & Trend Analysis by Treatment, and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. List of key distributors and channel partners
    • 7.2.2. Key company market share analysis, 2023
    • 7.2.3. NIPRO
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Fresenius Medical Care AG
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Baxter
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Medtronic
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. B. Braun SE
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Asahi Kasei Medical Co., Ltd.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. AbbVie Inc.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Nikkiso Co., Ltd.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. JMS Co., Ltd.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. AstraZeneca
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 4 North America renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 6 U.S. renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 8 Canada renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 Mexico renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13 Europe renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Germany renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 15 Germany renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 UK renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 18 France renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 France renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Italy renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 21 Italy renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Spain renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 Spain renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Denmark renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 Denmark renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Sweden renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 Sweden renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Norway renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 29 Norway renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 China renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 Japan renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 37 India renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 India renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 40 South Korea renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 Australia renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Thailand renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 44 Thailand renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 46 Latin America renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 47 Latin America renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Brazil renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 49 Brazil renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 51 Argentina renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 52 MEA renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 54 MEA renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 55 South Africa renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 56 South Africa renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 60 UAE renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 62 Kuwait renal failure treatment market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Renal failure treatment market: market outlook
  • Fig. 7 Renal failure treatment competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Renal failure treatment market driver impact
  • Fig. 11 Renal failure treatment market restraint impact
  • Fig. 12 Renal failure treatment market: Treatment movement analysis
  • Fig. 13 Renal failure treatment market: Treatment outlook and key takeaways
  • Fig. 14 Dialysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Hemodialysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Peritoneal dialysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Kidney transplantation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Drug therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Antihypertensive drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Antianemia therapeutics (erythropoiesis-stimulating agents) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Potassium binders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Phosphate binders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Renal failure treatment market: End use movement analysis
  • Fig. 25 Renal failure treatment market: End use outlook and key takeaways
  • Fig. 26 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Specialty clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Global renal failure treatment market: Regional movement analysis
  • Fig. 30 Global renal failure treatment market: Regional outlook and key takeaways
  • Fig. 31 Global renal failure treatment market share and leading players
  • Fig. 32 North America, by country
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. key country dynamics
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada key country dynamics
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico key country dynamics
  • Fig. 39 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 UK key country dynamics
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany key country dynamics
  • Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 France key country dynamics
  • Fig. 46 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Italy key country dynamics
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain key country dynamics
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark key country dynamics
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden key country dynamics
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway key country dynamics
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China key country dynamics
  • Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Japan key country dynamics
  • Fig. 61 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 India key country dynamics
  • Fig. 63 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand key country dynamics
  • Fig. 65 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea key country dynamics
  • Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Australia key country dynamics
  • Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil key country dynamics
  • Fig. 72 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Argentina key country dynamics
  • Fig. 74 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 South Africa key country dynamics
  • Fig. 77 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia key country dynamics
  • Fig. 79 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 UAE key country dynamics
  • Fig. 81 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Kuwait key country dynamics
  • Fig. 83 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Market share of key market players- renal failure treatment market